Potential for peptides to replace antibodies in radiopharma, says WuXi AppTec exec
Focus is turning to the development of peptide analogues of antibody-derived radiotherapeutics, according to Dr Dave Madge.
Triveni scores $115m to expand immunology pipeline
Shattuck Labs stock craters following pipeline and job cuts
Exscientia outline robot and AI use in drug discovery workflow
LoQus23 secures $43m to advance Huntington’s Disease therapy
Enara Bio secures $32.5m for ‘Dark Antigen’ cancer therapies
ImmunoPrecise and Biotheus partner on bispecific antibodies to treat cancer
Novaliq and Laboratoires Théa announce EC approval for dry eye disease therapy
Analysis
View More
Themes
View MoreTempus AI expands oncology collaboration with Takeda
Takeda's research team will leverage Tempus' Lens platform, which provides access to anonymised patient data.
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
Leading clinical trials companies in the artificial intelligence theme
Q2 2024 update: electronic medical record (emr) systems related private equity activity in the pharmaceutical industry
CMN-005 by CoImmune for Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue or MALT-Lymphoma): Likelihood of Approval
More Insights
Buyer's Guides
View More
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Phare Bio receives ARPA-H funds for AI drug discovery platform
AllazoHealth introduces AI offering to enhance medication initiation
AI boom set to revolutionise healthcare in Europe
Gilead and Genesis partner to create novel therapies using AI